{"address1": "555 Heritage Drive", "address2": "Suite 200", "city": "Jupiter", "state": "FL", "zip": "33458", "country": "United States", "phone": "858 550 7500", "website": "https://www.ligand.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; LYTENAVA to treat Opthamology; MEKINIST for cardiology; MINNEBRO for metabolic disease; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, JZP341, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; CE-furosemide for cardiology; CE-Meloxicam for neurology; V117, CX2101A, and Sitavig for infectious disease; REV-0100, OPT-302, and Reproxalap for opthamology; Vilazodone and Topiramate Injection for CNS; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.", "fullTimeEmployees": 68, "companyOfficers": [{"maxAge": 1, "name": "Mr. Todd C. Davis Ph.D.", "age": 63, "title": "CEO & Director", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1049967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Octavio  Espinoza", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 613587, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew T. Reardon J.D.", "age": 48, "title": "Chief Legal Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 614867, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul J. Hadden", "title": "Senior Vice President of Investments & Business Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Keith  Marschke Ph.D.", "title": "Senior Vice President of Biology & Scientific Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vincent D. Antle Ph.D.", "age": 55, "title": "Senior Vice President of Technical Operations & QA - Capitsol", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  Lucy", "title": "Senior VP & CBO Protein Expression Business", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen R. Reeves M.D.", "age": 73, "title": "Senior VP of Investments & Head of Clinical Strategy", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard B. Baxter", "title": "Senior VP of Investment Operation", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott M. Plesha", "age": 59, "title": "CEO of Pelthos Therapeutics", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 4, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://investor.ligand.com/Investors/Investor-Overview/default.aspx", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 105.14, "open": 104.95, "dayLow": 102.5, "dayHigh": 107.49, "regularMarketPreviousClose": 105.14, "regularMarketOpen": 104.95, "regularMarketDayLow": 102.5, "regularMarketDayHigh": 107.49, "exDividendDate": 1278028800, "payoutRatio": 0.0, "beta": 1.026, "forwardPE": 17.528427, "volume": 97782, "regularMarketVolume": 97782, "averageVolume": 107810, "averageVolume10days": 129930, "averageDailyVolume10Day": 129930, "bid": 76.21, "ask": 132.16, "bidSize": 1, "askSize": 1, "marketCap": 2018350976, "fiftyTwoWeekLow": 67.72, "fiftyTwoWeekHigh": 129.9, "priceToSalesTrailing12Months": 12.076317, "fiftyDayAverage": 113.7642, "twoHundredDayAverage": 107.2622, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1769335040, "profitMargins": -0.02412, "floatShares": 18843481, "sharesOutstanding": 19255400, "sharesShort": 955114, "sharesShortPriorMonth": 844954, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0496, "heldPercentInsiders": 0.020610001, "heldPercentInstitutions": 0.98468, "shortRatio": 7.25, "shortPercentOfFloat": 0.0681, "impliedSharesOutstanding": 19255400, "bookValue": 43.465, "priceToBook": 2.4115956, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -4032000, "trailingEps": -0.22, "forwardEps": 5.98, "lastSplitFactor": "1603:1000", "lastSplitDate": 1667347200, "enterpriseToRevenue": 10.586, "enterpriseToEbitda": 30.37, "52WeekChange": 0.40264952, "SandP52WeekChange": 0.08089435, "lastDividendValue": 9.357455, "lastDividendDate": 1175558400, "quoteType": "EQUITY", "currentPrice": 104.82, "targetHighPrice": 157.0, "targetLowPrice": 135.0, "targetMeanPrice": 143.57143, "targetMedianPrice": 141.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 256164992, "totalCashPerShare": 13.304, "ebitda": 58260000, "totalDebt": 7154000, "quickRatio": 8.046, "currentRatio": 8.934, "totalRevenue": 167132992, "debtToEquity": 0.861, "revenuePerShare": 9.138, "returnOnAssets": 0.01664, "returnOnEquity": -0.00527, "grossProfits": 134634000, "freeCashflow": 100785000, "operatingCashflow": 97047000, "revenueGrowth": 0.524, "grossMargins": 0.80555, "ebitdaMargins": 0.34858, "operatingMargins": 0.0394, "financialCurrency": "USD", "symbol": "LGND", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Ligand Pharmaceuticals Incorpor", "corporateActions": [], "preMarketTime": 1743596150, "regularMarketTime": 1743537601, "exchange": "NGM", "messageBoardId": "finmb_30820", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Ligand Pharmaceuticals Incorporated", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 722097000000, "preMarketChange": -0.5299988, "preMarketChangePercent": -0.5056275, "preMarketPrice": 104.29, "regularMarketChange": -0.3199997, "regularMarketDayRange": "102.5 - 107.49", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 107810, "fiftyTwoWeekLowChange": 37.1, "fiftyTwoWeekLowChangePercent": 0.54784405, "fiftyTwoWeekRange": "67.72 - 129.9", "fiftyTwoWeekHighChange": -25.079994, "fiftyTwoWeekHighChangePercent": -0.19307156, "fiftyTwoWeekChangePercent": 40.264954, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746442740, "earningsTimestampEnd": 1746792000, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.22, "epsForward": 5.98, "epsCurrentYear": 6.11, "priceEpsCurrentYear": 17.155483, "fiftyDayAverageChange": -8.944199, "fiftyDayAverageChangePercent": -0.0786205, "twoHundredDayAverageChange": -2.4421997, "twoHundredDayAverageChangePercent": -0.022768503, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -0.3043558, "regularMarketPrice": 104.82, "marketState": "PRE", "trailingPegRatio": null}